Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
CASE REPORTS OF RECALCITRANT LIVEDOID VASCULOPATHY TREATED WITH RIVAROXABAN
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shin, Jung Jin | - |
| dc.contributor.author | Lee, Ji Min | - |
| dc.contributor.author | Jang, Hee Won | - |
| dc.contributor.author | Jung, Sung Kyu | - |
| dc.contributor.author | Kim, Il-Hwan | - |
| dc.date.accessioned | 2021-09-05T04:52:44Z | - |
| dc.date.available | 2021-09-05T04:52:44Z | - |
| dc.date.created | 2021-06-15 | - |
| dc.date.issued | 2014-10 | - |
| dc.identifier.issn | 0385-2407 | - |
| dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97320 | - |
| dc.language | English | - |
| dc.language.iso | en | - |
| dc.publisher | WILEY-BLACKWELL | - |
| dc.title | CASE REPORTS OF RECALCITRANT LIVEDOID VASCULOPATHY TREATED WITH RIVAROXABAN | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Kim, Il-Hwan | - |
| dc.identifier.wosid | 000344332600373 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF DERMATOLOGY, v.41, pp.63 - 63 | - |
| dc.relation.isPartOf | JOURNAL OF DERMATOLOGY | - |
| dc.citation.title | JOURNAL OF DERMATOLOGY | - |
| dc.citation.volume | 41 | - |
| dc.citation.startPage | 63 | - |
| dc.citation.endPage | 63 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Dermatology | - |
| dc.relation.journalWebOfScienceCategory | Dermatology | - |
| dc.subject.keywordAuthor | Livedoid vasculopathy | - |
| dc.subject.keywordAuthor | LV | - |
| dc.subject.keywordAuthor | rivaroxaban | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.